Unseen Levels of Demand: Biotech's Breakout Star

Grab Shares in the Next Big Pharma Leader Grab Shares in the Next Big Pharma Leader                                                                                                      [Morning Watchlist] You are receiving this email because you are subscribed to Behind the Markets. If you no longer wish to receive these emails, please [unsubscribe]( here.  Dear Reader,  This is the only biotech company you should be watching right now.  No. It’s not Novo Nordisk, Pfizer, or Johnson & Johnson…  It’s a biotech firm which can’t keep up with “unprecedented” demand for its newest breakthrough drug.  [It sold 25,000 prescriptions per week just during its first month](.  Desperate patients are driving five hours just to get their prescriptions filled.  Bloomberg expects this new biotech breakthrough will be the best selling drug of all time.  And according to BMO bank, it will “dominate” a $90 billion pharma market.  The stock price of the firm behind it is already taking off.  [Get the stock ticker here…]( Our mailing address is: Behind the Markets, LLC 4260 NW 1st Avenue, Suite 55 Boca Raton, FL 33431 Copyright © 2024 Behind the Markets, LLC, All rights reserved. You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our [Privacy Policy]( or our [Legal Notices.]( [Behind the Markets](  [Unsubscribe]( Â